CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy, such as CCI-779, work in different ways to stop cancer cells from
dividing so they stop growing or die. This phase II trial is studying how well CCI-779 works
in treating patients with recurrent or refractory B-cell non-Hodgkin's lymphoma or chronic
lymphocytic leukemia.